Venture-Backed Startups
127,716 companies with verified investor relationships.
0 investors
0 investors
0 investors
CAHill TECH develops aQuiRe, a mobile app platform with safety and skills training videos for construction workers. The company provides workforce development and safety training solutions for construction companies and aspiring workers.
3 investors
CaHill Resources is a certified WBE, DBE, and WOSB provider of site contracting services and equipment rental, with a focus on heavy highway and civil construction. It serves projects including those involving governmental entities, handling their reporting and administrative requirements.
1 investor
0 investors
Cai is a browser-based music creation platform that combines AI-driven generation with digital audio workstation features, letting users record MIDI, audio, and voice-to-MIDI, arrange tracks on a canvas, and refine sound through conversational assistance. It serves musicians and music creators looking to produce music from text descriptions and editing tools.
1 investor
0 investors
Caidya is a contract research organization (CRO) that combines scientific, medical, and operational expertise to manage complex clinical development and cross-border trials. It provides clinical trial services and high-quality data to support decision-making in drug development.
1 investor
Cailabs designs and manufactures photonics products based on its proprietary Multi-Plane Light Conversion (MPLC) technology for laser applications, serving the industrial, telecommunications, and space and defense sectors. The company builds products for industrial lasers, telecom networks, and satellite-to-ground laser communications.
4 investors
0 investors
Caimera is an AI visual production platform that turns sketches and product ideas into fashion product images, videos, tech packs, and bulk catalogs using AI models and image generation. It serves fashion brands and e-commerce teams for design, marketing, and advertising visual content.
1 investor
0 investors
CAIPA Foundation is a not-for-profit funded mainly by physician members of the Chinese-American IPA that runs community service and health awareness programs for Asian American communities through education, advocacy, and access to culturally and linguistically tailored medical services. It offers assistance under the Medicaid 1115 Waiver Program, connecting eligible members in the Greater New York area to food, housing, and community resources in Mandarin, Cantonese, and English.
0 investors
Cair Health provides agentic automation software for revenue cycle management (RCM) in healthcare, helping billing teams process claims and documentation faster and more accurately.
3 investors
Caira Surgical develops joint replacement software, 3D scanning, and radar-based tracking technologies for orthopedic surgeons, with its first product being a navigation system for knee replacement. Its products are still in development and not yet marketed or registered.
0 investors
French medtech that developed an autonomous leadless pacemaker powered by cardiac energy harvesting.
2 investors
Caire Health develops AI software that analyzes medical imaging to assist emergency department teams in rapidly identifying critical conditions and triaging patients for immediate treatment.
1 investor
0 investors
Caire Beauty develops patented skincare products — including serums and a cleansing balm — formulated with triple-weight hyaluronic acid and bio-fermented peptides to address skin changes caused by hormonal shifts. It targets women experiencing menopause and hormone decline, positioning itself in the science-based skincare and beauty category.
1 investor
CAIRE develops and manufactures oxygen delivery equipment and services for medical and commercial applications, including products under its AirSep, HELiOS, and SeQual brands. Its customers include hospitals and military personnel who rely on high-performance oxygen delivery products.
1 investor
Cairn Therapeutics is a biopharmaceutical company developing oncology treatments intended to address drawbacks of standard chemotherapy such as side effects, low potency, and multidrug resistance. Its lead candidate, CT-262, is based on duocarmycin drug chemistry invented by Dale Boger at Scripps Research.
0 investors
Cairns Health develops voice-activated software and radar-based monitoring devices for patients with chronic conditions, delivering medication reminders, symptom assessments, and activity tracking to coordinate care teams and reduce clinical costs.
1 investor
0 investors